Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma-Reference-Cited by-同舟云学术

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma

Published:2019-10-26 Issue:2 Volume:25 Page:362-369
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Suppanuntaroek Sappaya,Hatakeyama Shingo^ORCID,Fujita Naoki,Kubota Yuka,Suzuki Yuichiro,Okamoto Teppei,Tobisawa Yuki,Yoneyama Tohru,Yamamoto Hayato,Mori Kazuyuki,Imai Atsushi,Yoneyama Takahiro,Hashimoto Yasuhiro,Ohyama Chikara

Funder

Japan Society for the Promotion of Scienc

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01563-2.pdf

Reference31 articles.

1. Quinten C, Coens C, Mauer M et al (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10(9):865–871

2. Di Maio M, Basch E, Bryce J et al (2016) Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol 13(5):319–325

3. Adeloye D, Harhay MO, Ayepola OO et al (2019) Estimate of the incidence of bladder cancer in Africa: a systematic review and Bayesian meta-analysis. Int J Urol 26(1):102–112

4. Iwamura H, Hatakeyama S, Sato M et al (2018) Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma. Med Oncol 35(6):94

5. Momota M, Hatakeyama S, Tokui N et al (2018) The impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma. Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.03.003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival;Urologia Internationalis;2022-10-14

2. Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study);International Journal of Clinical Oncology;2020-10-16